TREA

88190932 - HANSOH PHARMACEUTICAL

Follow

Information

  • Trademark
  • 88190932
  • Serial Number
    88190932
  • Filing Date
    November 12, 2018
    7 years ago
  • Transaction Date
    January 21, 2020
    5 years ago
  • Status Date
    January 20, 2020
    5 years ago
  • Published for Opposition Date
    April 23, 2019
    6 years ago
  • Location Date
    June 18, 2019
    6 years ago
Information
Mark Drawing Code
4000
Mark Identification
HANSOH PHARMACEUTICAL
Case File Statements
  • D10000: "PHARMACEUTICAL"
  • GS0051: Medicinal preparations for the treatment of central nervous system disease, depression, alzheimer's disease, insomnia, cancers, tumors, diabetes, digestion disease, cardiovascular disease; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Pharmaceutical preparations for the treatment of central nervous system disease, depression, alzheimer's disease, insomnia, cancers, tumors, diabetes, digestion disease, cardiovascular disease; Antibiotics; Antiseptics; Radioactive substances for medical purposes; Gases for medical and dental use; chemical conductors for electrocardiograph electrodes; Semen for artificial insemination; Disinfectants; Contact lens cleaning preparations; Cultures of microorganisms for medical and veterinary use; Dietetic foods adapted for medical purposes; Depuratives for the body; Veterinary preparations for treatment of intestinal bacteria; Biocides; sanitary pads; Medical dressings; Teeth filling material; Diapers for pets; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of central nervous system disease, depression, alzheimer's disease, insomnia, cancers, tumors, diabetes, digestion disease, cardiovascular disease; Vaccines; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Medicated serums for treatment of hair, skin, lips; Prescription synthetic narcotics; Biological preparations for medical purposes, namely, for the treatment of central nervous system disease, depression, alzheimer's disease, insomnia, cancers, tumors, diabetes, digestion disease, cardiovascular disease; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations, namely, elixirs for the treatment of central nervous system disease, depression, alzheimer's disease, insomnia, cancers, tumors, diabetes, digestion disease, cardiovascular disease; Cultures of microorganisms for medical and veterinary use
Case File Event Statements
  • 1/21/2020 - 5 years ago
    15 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 1/20/2020 - 5 years ago
    14 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 6/18/2019 - 6 years ago
    13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 4/23/2019 - 6 years ago
    12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/23/2019 - 6 years ago
    11 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/3/2019 - 6 years ago
    10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/18/2019 - 6 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 2/21/2019 - 6 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/21/2019 - 6 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/21/2019 - 6 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/21/2019 - 6 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/21/2019 - 6 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/14/2019 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/30/2018 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 11/15/2018 - 7 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP